Dementia Clinical Trials 2024

Dementia Clinical Trials 2024

Dementia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in dementia clinical trials today.

Dementia Clinical Trials

Here are the 6 most popular medical studies for dementia

Popular filter options for dementia trials

Alzheimer's Disease Clinical Trials

View 86 Alzheimer's Disease medical studies.

Mild Cognitive Impairment Clinical Trials

View 54 Mild Cognitive Impairment medical studies.

Phase 3 Dementia Clinical Trials

View 98 phase 3 dementia medical studies.

Dementia Clinical Trials With No Placebo

View 98 dementia medical studies that do not have a placebo group.

View More Dementia Trials

See another 75 medical studies focused on dementia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to dementia

What are the top hospitals conducting dementia research?

When it comes to advancing our understanding and treatment of dementia, several hospitals are leading the charge in clinical trials. In Cleveland, Case Western Reserve University has emerged as a prominent institution with three active trials focused on dementia. Since conducting their first recorded trial in 2019, they have contributed significantly to the field with six completed studies thus far. Similarly, the University of Minnesota in Minneapolis is making a significant impact through its ongoing collaborations on three active dementia trials and nine total trials since their initial research endeavor in 2018.

In Sun City at Banner Sun Health Research Institute, researchers have piloted groundbreaking investigations into dementia for over a decade. With three current clinical trials underway and an impressive sixteen completed studies under their belt since 2009, this institute continues to play a vital role in expanding our knowledge of this complex condition.

Meanwhile, Progressive Medical Research in Port Orange joins the ranks with its dedication to dementia research. Like their counterparts mentioned earlier, they currently conduct three active clinical trials and have made notable contributions through five previous studies since initiating their inaugural trial also back in 2019.

Finally, we look towards Missouri where the University of Missouri holds its own significance regarding dementia research. Though smaller-scale compared to some other institutions mentioned here; two ongoing clinical tests thrive alongside another fascinating aspect that marks them trailblazers around limited resources-three accomplished experiments conducted between timescales starting from early days tracing back until2003.

These hospitals represent beacons of hope for individuals affected by this debilitating condition and serve as pioneers shaping future treatments for better quality-of-life outcomes worldwide.

Which are the best cities for dementia clinical trials?

In the realm of dementia clinical trials, several cities stand out as hubs for research and exploration. Seattle, Washington leads with 13 active trials focused on a range of interventions like Survey-based Patient/Clinician Jumpstart and STAR-VTF. Toronto, Ontario follows closely behind with 9 ongoing studies investigating treatments including Escitalopram and VR&R Therapy. San Francisco, California also showcases its commitment to advancing dementia care through 9 active trials centered around Brain Health Intervention and Cognitive Training. Together, these cities offer individuals affected by dementia access to cutting-edge clinical trials that hold promise for improved understanding and management of this complex condition.

Which are the top treatments for dementia being explored in clinical trials?

Clinical trials for dementia are paving the way for new treatments and hope. Taking center stage is intervention, currently being explored in four active trials dedicated to dementia. Since its first listing in 2013, it has garnered a total of five trials focused on this debilitating condition. Close behind is cognitive training, with two ongoing trials and a history of four all-time dementia studies since its debut in 2019. These innovative approaches hold promise for improving the lives of those affected by dementia, offering glimpses of light amidst the challenges they face.

What are the most recent clinical trials for dementia?

Recent clinical trials bring hope to the field of dementia research, offering potential advancements in diagnosis, treatment, and care. One notable study explores the use of 123I-MIBG scintigraphy as a diagnostic tool for dementia. Another trial investigates the efficacy of Donanemab at dose level 4 in improving cognitive function and slowing disease progression. Additionally, an experimental treatment involving XPro1595 shows promise in addressing symptoms associated with dementia. Predicted Responders is another intriguing trial that aims to identify individuals who are likely to benefit from specific interventions. Finally, a Phase 3 study focuses on hearing intervention (HI) groups and their impact on mitigating cognitive decline related to dementia. These trials present diverse approaches towards understanding and combating this complex condition.

What dementia clinical trials were recently completed?

In the realm of dementia research, several noteworthy clinical trials have recently wrapped up, providing valuable insights into potential treatments. In April 2022, BioXcel Therapeutics Inc. completed a trial examining BXCL501's efficacy in addressing this debilitating condition. Prior to that, Eisai Inc.'s E2027 trial concluded in February 2021, followed by Axsome Therapeutics' AXS-05 study and Woolsey Pharmaceuticals' investigation on Oral Fasudil 90 mg/day both completing in December 2020. Moreover, Athira Pharma's ATH-1017 trial reached its endpoint in November 2020. These trials contribute to our understanding of various therapeutic avenues for dementia treatment and highlight ongoing efforts within the scientific community to combat this challenging disease effectively.